1 71 studies reported on
lifetime prevalence.
2 significant public health issue, with a 25%
lifetime prevalence.
3 ence 1.03 [0.79-1.33], p for trend=0.46; for
lifetime prevalence 0.99 [0.83-1.23], p for trend=0.93).
4 Lifetime prevalence (
2.30 [1.50-3.52]) and one-year prev
5 BV care cascade in five distinct stages: (1)
lifetime prevalence; (
2) diagnosis; (3) engagement with
6 ), but cigar use was also substantial (37.1%
lifetime prevalence,
23.0% past-year prevalence, and 8.5
7 s (50.8%) only slightly higher than observed
lifetime prevalence (
46.4%).
8 ain outcome was the retrospectively reported
lifetime prevalence and 12-month persistence (estimated
9 Lack of data on the
lifetime prevalence and age at onset of suicide ideation
10 We herein present
lifetime prevalence and comorbidity rates of Axis I diso
11 We seek to estimate
lifetime prevalence and demographic correlates of nonaff
12 The authors found a substantially higher
lifetime prevalence and incidence of anorexia nervosa th
13 The study indicated a considerably high
lifetime prevalence and incidence of VTE during residenc
14 As the
lifetime prevalence and life expectancy of individuals w
15 We generated temporal trends in
lifetime prevalence and methods of, and motivations for,
16 We sought to estimate the
lifetime prevalence and overall characteristics of anaph
17 We estimated
lifetime prevalence and point prevalence of vaginal fist
18 The
lifetime prevalence and probandwise concordance rates fo
19 Child
lifetime prevalence and relative risks of psychiatric di
20 The authors evaluated
lifetime prevalence and specificity of DSM-IV psychiatri
21 the most common of psychiatric diseases (28%
lifetime prevalence)
and contribute to the aetiology of
22 me prevalence), social anxiety disorder (13%
lifetime prevalence),
and panic disorder (5.2% lifetime
23 In this sample, 25.1% had a
lifetime prevalence,
and 3.3% were incident cases with a
24 New ADHD diagnoses, ADHD
lifetime prevalence,
and ADHD medication use.
25 establish whether they described current or
lifetime prevalence,
and those with discrepancies in the
26 The
lifetime prevalence (
approximately 16%) and the economi
27 Increasing
lifetime prevalences are found in recent cohorts.
28 Lifetime prevalence by meta-analysis was shown to be 24.
29 y and sexually transmitted infections [STIs]
lifetime prevalence,
condom use, and use of other forms
30 sented nationally representative data on the
lifetime prevalence,
correlates, and comorbidity of shop
31 lt and to illustrate one way of dealing with
lifetime prevalence data.
32 Lifetime prevalence estimates are 22.7% for isolated pan
33 Lifetime prevalence estimates are as follows: anxiety di
34 Country-specific
lifetime prevalence estimates are consistently (median;
35 Lifetime prevalence estimates are higher in recent cohor
36 The respective
lifetime prevalence estimates ascertained by retrospecti
37 Lifetime prevalence estimates of anorexia nervosa, bulim
38 Lifetime prevalence estimates of childhood and adult sep
39 rthermore, no previous studies have compared
lifetime prevalence estimates of common physical disorde
40 In contrast, retrospective
lifetime prevalence estimates of physical disorders asce
41 Lifetime prevalence estimates of psychosis in community
42 The
lifetime prevalence estimates of suicidal ideation, suic
43 Significant variations of
lifetime prevalence estimates were presented by study pe
44 Among 4 ethnic-sex groups, the 7.5%
lifetime prevalence for attempts among Caribbean black m
45 ording to large US cohort studies, estimated
lifetime prevalences for anorexia nervosa, bulimia nervo
46 Lifetime prevalences for depressive, anxiety, and substa
47 on and severe illnesses which have estimated
lifetime prevalences in the region of 0.8% for bipolar a
48 Lifetime prevalences,
incidence rates, and 5-year recove
49 will appear to be nonrandom comorbidity when
lifetime prevalence is used with mixed-age samples.
50 Neither
lifetime prevalence nor age at onset were related to ADR
51 g and diverse mental health condition with a
lifetime prevalence of 0.4%.
52 hypersensitivity reaction with an estimated
lifetime prevalence of 0.5-2.0%.
53 associated with significant impairment and a
lifetime prevalence of 1% to 3%; however, it is often mi
54 oung men aged 13 to 20 years had the highest
lifetime prevalence of 11.68% (95% CI, 11.56%-11.81%) in
55 Americans and Caribbean Americans, reported
lifetime prevalence of 11.7% for suicide ideation and 4.
56 eating behavior and occur worldwide, with a
lifetime prevalence of 2% to 5%.
57 Panic disorder (PD) has a
lifetime prevalence of 2-4% and heritability estimates o
58 k pain (CBP) is a disabling condition with a
lifetime prevalence of 40% and a substantial socioeconom
59 as 36.0% (95% CI 20.4-55.2), compared with a
lifetime prevalence of 47.2% (31.7-63.3).
60 4 million people annually worldwide, with a
lifetime prevalence of 5% to 10%.
61 ray, Ethiopia, reported a neonatal mortality
lifetime prevalence of 7.13 deaths.
62 We aimed to evaluate the
lifetime prevalence of ACEs and their associations with
63 The
lifetime prevalence of ACEs is substantially higher amon
64 -reviewed studies in English that documented
lifetime prevalence of ACEs or associations between ACEs
65 The
lifetime prevalence of ADHD in the study sample was 2.6%
66 Lifetime prevalence of ADHD increased by 2.7-fold during
67 Lifetime prevalence of ADHD medication purchases was 0.5
68 Overall
lifetime prevalence of AI-SUPERPFP DSM-IV disorders rang
69 scents with firearm access also had a higher
lifetime prevalence of alcohol abuse (10.1% vs 3.8%, P <
70 ffect the population prevalence; the present
lifetime prevalence of all eating disorders is about 5%.
71 6390 [4190-9550] vs 0 [0-0]; P < .0001), and
lifetime prevalence of allergic diseases was significant
72 stimates for all age groups of self-reported
lifetime prevalence of allergy to cow's milk, egg, wheat
73 The goal of this study was to examine the
lifetime prevalence of antisocial personality disorder a
74 isorder (n=1939) showed no difference in the
lifetime prevalence of anxiety disorders between these s
75 In this study, we aimed to quantify the
lifetime prevalence of anxiety disorders in individuals
76 , South America, and Asia, indicate that the
lifetime prevalence of anxiety disorders in individuals
77 Despite the elevated
lifetime prevalence of anxiety disorders, effective stra
78 rinkers (950 million heavy drinkers) and the
lifetime prevalence of any alcohol use disorder (AUD) is
79 bipolar disorder, in which we quantified the
lifetime prevalence of any anxiety disorder in people wi
80 e interval, 1.22-13.40; P =.02) and a higher
lifetime prevalence of any of the syndrome disorders (co
81 The
lifetime prevalence of any psychiatric comorbidity among
82 Lifetime prevalence of any stimulant use was 14.8%, with
83 xperience major depression each year, with a
lifetime prevalence of approximately 17% for men and 30%
84 ory skin disease with early onset and with a
lifetime prevalence of approximately 20%.
85 Anxiety disorders have a
lifetime prevalence of approximately 34% in the US, are
86 The
lifetime prevalence of atopic dermatitis was high (34.1%
87 The
lifetime prevalence of atopic diseases was high and incr
88 lder than age 4, showed an eightfold greater
lifetime prevalence of attention deficit hyperactivity d
89 In a cross-national survey, the average
lifetime prevalence of binge eating disorder (BED) was 2
90 In the general adult population, the
lifetime prevalence of BPD has been reported to be from
91 ere was large variation in the self-reported
lifetime prevalence of cervical cancer screening among c
92 ation between countries in the self-reported
lifetime prevalence of cervical cancer screening.
93 The US
lifetime prevalence of childhood epilepsy was 1.03% and
94 Lifetime prevalence of comorbid DSM-IV-TR disorders, the
95 Lifetime prevalence of comorbid mental/substance use dis
96 Lifetime prevalence of Composite International Diagnosti
97 This paper describes
lifetime prevalence of consensual male-male sexual behav
98 , no representative epidemiologic studies of
lifetime prevalence of dating violence among adolescents
99 be associated with a reduction in cumulative
lifetime prevalence of depression by 14.7%, 12.9%, and 1
100 amples, study quality, age of the sample, or
lifetime prevalence of depression.
101 opulation study, we examined the current and
lifetime prevalence of depressive disorders in 4,559 non
102 Twelve-month and
lifetime prevalence of drug abuse and dependence and the
103 The
lifetime prevalence of DSM-5 anorexia nervosa among wome
104 We did a random-effects meta-analysis of
lifetime prevalence of DSM-III and DSM-IV anxiety disord
105 tudies that reported original data about the
lifetime prevalence of DSM-III and DSM-IV anxiety disord
106 The
lifetime prevalence of DSM-IV anorexia nervosa was 2.2%,
107 des, prevalence of anabolic steroid use, and
lifetime prevalence of DSM-IV mood, anxiety, and eating
108 rect relation between both 1-year period and
lifetime prevalence of eczema and water hardness, both b
109 Questionnaire details of 1-year period and
lifetime prevalence of eczema were obtained from parents
110 ed from 30% to 44%, the estimated cumulative
lifetime prevalence of epilepsy using Kaplan-Meier appro
111 nical details were collected, and cumulative
lifetime prevalence of epilepsy was determined using the
112 Lifetime prevalence of exposure to traumatic events and
113 adults was 89.8% (95% CI 83.7-93.7) and the
lifetime prevalence of four or more ACEs was 53.9% (45.9
114 e also significantly moderated the estimated
lifetime prevalence of four or more ACEs.
115 This prospective study suggests that the
lifetime prevalence of GAD and MDD may be underestimated
116 The
lifetime prevalence of having at least 1 suicide attempt
117 The
lifetime prevalence of IDU among Iranian incarcerated pe
118 This study documents a high
lifetime prevalence of injection drug use in a group of
119 a mean age of 17 years, cases showed a 23.4%
lifetime prevalence of major affective disorders compare
120 n and controlling for age and education, the
lifetime prevalence of major depression in the head inju
121 Estimated
lifetime prevalence of major depression was 20.4% in wom
122 However, the
lifetime prevalence of major depressive disorder, posttr
123 evaluations substantially underestimated the
lifetime prevalence of mental disorders as compared with
124 Lifetime prevalence of mental disorders was 53.2% (95% C
125 n surveys may consistently underestimate the
lifetime prevalence of mental disorders.
126 individuals exhibited a significantly higher
lifetime prevalence of mental health disorders (86%; 95%
127 Current and
lifetime prevalence of mental health disorders among peo
128 The
lifetime prevalence of migraine was significantly higher
129 The
lifetime prevalence of mood disorder in this group was 6
130 The
lifetime prevalence of mood disorders such as major depr
131 r is a critical public health problem with a
lifetime prevalence of nearly 17% in the United States.
132 s a debilitating psychiatric disorder with a
lifetime prevalence of nearly 8% in the general populati
133 This is the first study of the incidence and
lifetime prevalence of neurological disorders in recent
134 In three of these practices, the
lifetime prevalence of neurological disorders was also a
135 The
lifetime prevalence of neurological disorders was survey
136 Lifetime prevalence of nicotine dependence was 24%, near
137 The
lifetime prevalence of non-war-related sexual assault co
138 The
lifetime prevalence of OCD was significantly higher in c
139 rauma was found in 285 participants, and the
lifetime prevalence of ocular injury (95% CI) was 5.2% (
140 Lifetime prevalence of one or more ACEs among homeless a
141 t tool significantly moderated the estimated
lifetime prevalence of one or more ACEs and four or more
142 We calculated pooled estimates of
lifetime prevalence of one or more ACEs and four or more
143 We also document that the reported
lifetime prevalence of open science practices increased
144 patients with IC had a significantly higher
lifetime prevalence of PD (controlling for age and sex)
145 The primary outcomes were
lifetime prevalence of psychiatric issues, prescription
146 The
lifetime prevalence of PTSD among these chemically depen
147 The
lifetime prevalence of PTSD was 29.6% (24.3% for males a
148 re an isolated population in Micronesia with
lifetime prevalence of schizophrenia (SCZD) of 2%, compa
149 The
lifetime prevalence of schizophrenia was 2.0%, with a ma
150 Lifetime prevalence of selected mental and physical diso
151 lly distributed questionnaire, to assess the
lifetime prevalence of self-identified depression and su
152 While
lifetime prevalence of self-reported FA and food challen
153 ional study of US adults, differences in the
lifetime prevalence of skin cancer among SM adults compa
154 Self-reported
lifetime prevalence of skin cancer by sexual orientation
155 The
lifetime prevalence of skin cancer was overall higher am
156 Lifetime prevalence of substance use disorders was 29.1%
157 population survey data are presented on the
lifetime prevalence of suicide attempts as well as trans
158 Several recent studies have found a higher
lifetime prevalence of suicide attempts in homosexual ma
159 Lifetime prevalence of suicide in the general population
160 The estimate of the
lifetime prevalence of suicide in those ever hospitalize
161 , 12-month prevalence among respondents with
lifetime prevalence of the disorder), in comparison, was
162 The
lifetime prevalence of traumatic events was 40% and of P
163 The
lifetime prevalence of various provider-diagnosed mental
164 The global
lifetime prevalence of vitiligo diagnosed by a physician
165 he worldwide, regional, and country-specific
lifetime prevalence of vitiligo diagnosed by physicians
166 The
lifetime prevalence of voice problems was 24.3%, and cur
167 The
lifetime prevalence of VTE at baseline was 9.6% (95% CI
168 The primary endpoint of this study was the
lifetime prevalence of VTE, and the secondary endpoint w
169 Twelve-month and
lifetime prevalences of AUD were 13.9% and 29.1%, respec
170 Twelve-month and
lifetime prevalences of AUD.
171 By computer algorithm,
lifetime prevalences of narrowly and broadly defined psy
172 Strong associations were found between the
lifetime prevalences of panic and major depressive episo
173 Women exhibit higher
lifetime prevalences of stress-related disorders than me
174 The estimated
lifetime prevalences of suicide ideation, plans, and att
175 Little is known about
lifetime prevalence or age of onset of DSM-IV disorders.
176 To examine changes in the
lifetime prevalence,
patterns, and associated demographi
177 reported to be between 18% and 31%, whereas
lifetime prevalence ranges between 6.7% and 66.7%.
178 Results from studies showed that the
lifetime prevalence rate of bipolar II disorder in adult
179 Lifetime prevalence rates are also reported (expressed a
180 No differences were found in
lifetime prevalence rates between migrant and U.S.-born
181 ican Prevalence and Services Survey presents
lifetime prevalence rates for 12 DSM-III-R psychiatric d
182 Lifetime prevalence rates for all three disorders were h
183 The
lifetime prevalence rates for panic disorder ranged from
184 Lifetime prevalence rates in various countries for bipol
185 Elevated
lifetime prevalence rates of alcohol use disorders (AUDs
186 greater seafood consumption predicted lower
lifetime prevalence rates of bipolar I disorder, bipolar
187 Lifetime prevalence rates of eating disorders, mood diso
188 By clinician diagnosis,
lifetime prevalence rates of narrowly and broadly define
189 Lifetime prevalence rates of physical and sexual dating
190 The absence of a correlation between
lifetime prevalence rates of schizophrenia and seafood c
191 Lifetime prevalence rates were lower among SM females co
192 reafter, we recommend that any future use of
lifetime prevalence should require determination of the
193 Generalized anxiety disorder (6.2%
lifetime prevalence),
social anxiety disorder (13% lifet
194 In estimating
lifetime prevalence,
studies reporting point or period p
195 ental Health Survey (SNMHS), we examined the
lifetime prevalence,
treatment, and socio-demographic co
196 blems in children was 6.7% (n = 78), and the
lifetime prevalence was 12% (n = 138).
197 Lifetime prevalence was 3.0 cases (95% credible interval
198 Lifetime prevalence was 71.6% for alcohol and 30% for il
199 omelessness was 67% (95% CI, 55-77), and the
lifetime prevalence was 77% (95% CI, 61-88).
200 Lifetime prevalence was estimated as 163,309 (1.34%) ove
201 e reactive antigen or nucleic acid test, and
lifetime prevalence was estimated as the sum of diagnose
202 The corresponding values for
lifetime prevalence were 25.4% (384/1509) and 21.2% (167
203 stimates for all age groups of self-reported
lifetime prevalence were as follows: cow's milk (5.7%, 9
204 ble studies; both current (up to 1 year) and
lifetime prevalence were extracted, if available.
205 The aggregate
lifetime prevalences were 0.6% for bipolar type I disord
206 Lifetime prevalences were 31% in women and 24% in men fo
207 Lifetime prevalences were 32.5% and 5.7%, respectively.
208 f psychiatric comorbidity have been based on
lifetime prevalence with mixed-age samples, a practice t
209 Use of
lifetime prevalence with mixed-age samples, used almost
210 fetime prevalence), and panic disorder (5.2%
lifetime prevalence)
with or without agoraphobia are com
211 psychiatric diseases, with an estimated 28%
lifetime prevalence worldwide.